분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2015-01-06 02:52:39 , Hit : 925
 Scientists explain how stem cells and 'bad luck' cause cancer


January 2, 2015, 5:48 PM

Why are some types of cancer so much more common than others? Sometimes it’s due to faulty genes inherited from one’s parents and sometimes to behaviors like smoking a pack of cigarettes every day. But in most cases, it comes down to something else – stem cells..

This is the intriguing argument made by a pair of researchers from Johns Hopkins University. In a study published Friday in the journal Science, they found a very high correlation between the differences in risk for 31 kinds of cancer and the frequency with which different types of stem cells made copies of themselves.

Just how strong was this link? On a scale that goes from 0 (absolutely no correlation) to 1 (exact correlation), biostatistician Cristian Tomasetti and cancer geneticist Bert Vogelstein calculated that it was at least a 0.8. When it comes to cancer, that’s high.

“No other environmental or inherited factors are known to be correlated in this way across tumor types,” Tomasetti and Vogelstein wrote.

Researchers have long recognized that when cells copy themselves, they sometimes make small errors in the billions of chemical letters that make up their DNA. Many of these mistakes are inconsequential, but others can cause cells to grow out of control. That is the beginning of cancer.

The odds of making a copying mistake are believed to be the same for all cells. But some kinds of cells copy themselves much more often than others. Tomasetti and Vogelstein hypothesized that the more frequently a type of cell made copies of itself, the greater the odds that it would develop cancer.

The pair focused on stem cells because of  their outsized influence in the body. Stem cells can grow into many kinds of specialized cells, so if they contain damaged DNA, those mistakes can spread quickly.

The researchers combed through the scientific literature and found studies that described the frequency of stem cell division for 31 different tissue types. Then they used data from the National Cancer Institute’s Surveillance, Epidemiology and End Results database to assess the lifetime cancer risk for each of those tissue types. When they plotted the total number of stem cell divisions against the lifetime cancer risk for each tissue, the result was 31 points clustered pretty tightly along a line.

To put this notion in concrete terms, consider the skin. The outermost layer of the skin is the epidermis, and the innermost layer of the epidermis contains a few types of cells. Basal epidermal cells are the ones that copy themselves frequently, with new cells pushing older ones to the skin’s surface. Melanocytes are charged with making melanin, the pigment that protects the skin from the sun’s damaging ultraviolet rays.

When sunlight hits bare skin, both basal epidermal cells and melanocytes get the same exposure to UV. But basal cell carcinoma is far more common than melanoma – about 2.8 million Americans are diagnosed with basal cell carcinoma each year, compared with roughly 76,000 new cases of melanoma, according to the Skin Cancer Foundation. A major reason for this discrepancy, Tomasetti and Vogelstein wrote, is that epidermal stem cells divide once every 48 days, while melanocytes divide only once every 147 days.

Overall, the researchers calculated that 65% of the variation in the risk of different types of cancer can be explained by how often stem cells copy themselves.


ADVERTISEMENT

The pair also determined that some cancers – including lung cancer in smokers and hepatocellular carcinoma in patients with hepatitis C – occur more frequently than their stem cell replication rate would suggest. In these cases, getting people to change their behavior can prevent many cases of cancer, Tomasetti and Vogelstein wrote.

But for most of the tumor types they analyzed, a cancer diagnosis comes down to little more than “bad luck,” they wrote. There’s not much that patients can do to prevent these cancers, they added, so doctors should focus on finding them early when they are more susceptible to treatment.

For more cutting-edge science, follow me on Twitter @LATkarenkaplan and "like" Los Angeles Times Science & Health on Facebook.

Copyright © 2015, Los Angeles Times







1007   US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments  이성욱 2015/01/08 1664
1006   Janssen, Isis Pharma Ink Up-to-$835M Antisense Agreement  이성욱 2015/01/07 1180
1005   CVS Gives Preferred Status to Gilead’s Hepatitis C Drugs  이성욱 2015/01/07 1302
1004   Mass. developer of messenger RNA drugs gets $450M funding boost  이성욱 2015/01/07 965
1003   아직도 풀리지 않은 STAP줄기세포 미스터리  이성욱 2015/01/06 1009
1002   에볼라 확산원인에 대한 새로운 주장  이성욱 2015/01/06 1113
  Scientists explain how stem cells and 'bad luck' cause cancer  이성욱 2015/01/06 925
1000   자가 항체에 의한 전신 홍반성 루프스 발생 기작  이성욱 2015/01/05 1551
999   줄기세포로 만든 초기 난자와 정자  이성욱 2014/12/31 1146
998   텔로머레이즈 기반 유전자 요법으로 심장마비 치료  이성욱 2014/12/24 1662
997   일본의 검증팀 STAP 세포 재현 포기, 오보카타 사임  이성욱 2014/12/23 1074
996   아수라장 속에서 탄생한 생명  이성욱 2014/12/17 1237
995   암 생존율을 높일 수 있는 면역세포  이성욱 2014/12/16 1091
994   FDA approves 9-valent HPV vaccine for certain cancers  이성욱 2014/12/12 1141
993   C형 간염 치료에서 비용 효율성을 보인 시메프레비르(simeprevir) 기반 요법  이성욱 2014/12/11 1710
992   Y 염색체 상실을 초래할 수 있는 흡연  이성욱 2014/12/10 1338
991   술의 역사: 영장류가 진화한 것은 알코올 섭취능력 때문?  이성욱 2014/12/04 1266
990   혈우병 환자들에게 안전성과 효과를 입증한 유전자 요법  이성욱 2014/11/27 1613
989   EMA panel recommends approval of DAA regimen for patients with HCV  이성욱 2014/11/26 1281
988   AMD를 치료하는데 사용될 수 있는 HIV/AIDS 약물들  이성욱 2014/11/26 1391

[이전 10개] [1]..[11][12][13] 14 [15][16][17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN